XW0434AIntroduction of Cefepime-taniborbactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 10

New Technology›Anatomical Regions›Introduction

Billable / Specific Code

ICD-10-PCS XW0434A

CMS Source: FY 2026 ICD-10-PCS dataset. Effective Oct 1, 2025 – Sep 30, 2026.

XW0434A is a billable ICD-10-PCS procedure code for Introduction of Cefepime-taniborbactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 10. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

Code Identity

ICD-10-PCS Code

XW0434A

Billable Status

Yes — Valid for Submission

Code Describes

Introduction of Cefepime-taniborbactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 10

Parent Code

XW0

Short Description

Introduce Cefe-taniborb in Central Vein, Perc, New Tech 10

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

Position	Designation	Value	Meaning
1	Section	X	New Technology
2	Body System	W	Anatomical Regions
3	Operation	0	Introduction
4	BodyPart	4	Central Vein
5	Approach	3	Percutaneous
6	Device/Substance/Technology	4	Cefepime-taniborbactam Anti-infective
7	Qualifier	A	New Technology Group 10

Code History

Replaces previously assigned code(s):

3E04329 — Introduce Oth Anti-infect in Central Vein, Perc

Similar Procedure Codes

Filter related codes list:

Questions About XW0434A

Is XW0434A a billable code?

Yes. XW0434A is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Cefepime-taniborbactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 10 on inpatient claims from October 1, 2025 through September 30, 2026.

What do the characters in XW0434A mean?

XW0434A breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character 4 is the BodyPart (Central Vein); the 5th character 3 is the Approach (Percutaneous); the 6th character 4 is the Device/Substance/Technology (Cefepime-taniborbactam Anti-infective); the 7th character A is the Qualifier (New Technology Group 10).